| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CLGC.2013.09.008 |
| P698 | PubMed publication ID | 24268852 |
| P50 | author | Bernard Escudier | Q54553923 |
| P2093 | author name string | Stephane Oudard | |
| Alain Ravaud | |||
| Christine Chevreau | |||
| Sylvie Négrier | |||
| Eric Amela | |||
| Remy Delva | |||
| Ellen Blanc | |||
| Diego Tosi | |||
| Frederic Rolland | |||
| Celine Ferlay | |||
| French Group on Renal Cancer | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 50-54 | |
| P577 | publication date | 2013-09-28 | |
| P1433 | published in | Clinical Genitourinary Cancer | Q332266 |
| P1476 | title | A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases | |
| P478 | volume | 12 |
| Q59811941 | Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports |
| Q55036256 | Anti-angiogenic therapies in brain metastases. |
| Q38627885 | Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib |
| Q91599016 | Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus |
| Q39229266 | Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). |
| Q89521108 | Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma? |
| Q90410649 | Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases |
| Q33814322 | Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma. |
| Q92159175 | Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? |
| Q90811589 | Les métastases cérébrales de cancer du rein, un défi clinique |
| Q92593427 | No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases |
| Q38631975 | Oral Targeted Therapies and Central Nervous System (CNS) Metastases |
| Q36642545 | Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE). |
| Q64913810 | Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma. |
| Q52145713 | Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer. |
| Q38799848 | Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma |
| Q49956245 | Targeted therapy of brain metastases: latest evidence and clinical implications |
| Q38564085 | The future of targeted therapies for brain metastases |
| Q90811559 | Traitement focal et traitement systémique dans la prise en charge du cancer du rein métastatique : une question de complémentarité |
| Q53827061 | Treatment of Brain Metastases. |
| Q98178296 | Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases |
Search more.